丸美生物旗下子品牌春纪近日关闭天猫旗舰店。丸美生物就此引发的关注回应称，这是基于该品牌业务 发展的实际情况早已规划的正常运营端调整，是该品牌"战略收缩的后续执行环节"。其强调这不是近期 仓促的决定，而是"主动优化品牌组合、高效配置资源的战略体现"。丸美生物称会将优势资源聚焦于核 心业务与未来增长赛道。（界面） ...

证券之星消息，10月22日化妆品板块较上一交易日下跌0.72%，拉芳家化领跌。当日上证指数报收于 3913.76，下跌0.07%。深证成指报收于12996.61，下跌0.62%。化妆品板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002094 | 青岛金王 | 3074.03万 | 6.83% | -407.02万 | -0.90% | -2667.01万 | -5.93% | | 300132 青松股份 | | 1427.69万 | 7.73% | -2606.26万 | -14.11% | 1178.57万 | 6.38% | | 300849 锦盛新材 | | 449.78万 | 5.82% | -311.49万 | -4.03% | -138.30万 | -1.79% | | 300957 | 贝泰妮 | 236.31万 | 1.93% | 185.90万 | 1.52% | -422 ...

证券之星消息，10月21日化妆品板块较上一交易日下跌0.03%，拉芳家化领跌。当日上证指数报收于 3916.33，上涨1.36%。深证成指报收于13077.32，上涨2.06%。化妆品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603630 | 拉芳家化 | 22.97 | -2.67% | 6.15万 | 1.41亿 | | 600315 | 上海家化 | 27.09 | -1.85% | 9.64万 | 2.62 Z | | 300740 | 水羊股份 | 22.93 | -0.91% | 18.56万 | 4.22亿 | | 300856 | 科恩股份 | 13.68 | -0.65% | 4.02万 | 5493.77万 | | 300957 | 贝泰妮 | 45.94 | -0.02% | 3.08万 | 1.41亿 | | 603605 | 珀莱雅 | 77.75 | 0.06% | 3.42万 | 2.66亿 | | 603983 | 丸美生物 | 36. ...

来源：北京商报 丸美生物将注意力从春纪转移到彩妆品牌恋火身上的战略调整或许不难理解，2019年前后，随着国潮彩 妆风的崛起，兴起了不少国产彩妆品牌，在流量营销的加持下，像完美日记、花西子、采棠等都先后崛 起，成为颇受欢迎的国货彩妆品牌，与恋火的崛起及发展如出一辙。 美妆资深评论人、美云空间电商创始人白云虎表示，春纪品牌"下线"的核心原因，表面上是因为业绩表 现没有达到预期，但本质还是品牌定位不清晰，经营策略波动，使用户的需求模糊，导致老用户"逃 离"、新用户"犹豫"，最终无法沉淀消费用户，业绩也难以持续。 "对于春纪而言，丸美生物前期投入也不少，也赋予了很多的预期。但对于春纪来说，需要的是更明确 独特的定位和渠道策略，才能走出真正的差异化。当然，春纪全面撤离线上，也可能是丸美生物在筹划 布局另一个'新模式'。但我个人认为，如果春纪不能舍离旧模式，仍然在传统模式下运营，结果其实已 经显现了。"白云虎说道。 与此同时，记者了解到，该品牌位于京东、楚楚街、蘑菇街、拼多多、卷皮等多家主流电商平台的店铺 已全部关闭。春纪微信公众号也早于2023年初停更；而春纪官方微博于2022年5月停更。 值得一提的是，北京商报记者在 ...

Core Viewpoint - The beauty brand Chunji under Marubi Bio is quietly exiting the market, with its flagship store on major e-commerce platforms closed and no new products launched since July 2024 [1][2][3]. Group 1: Brand Performance and Market Presence - Chunji's flagship store on Tmall announced its intention to cease operations by October 26, 2025, and has already removed all product links since August 2023 [1]. - The brand has closed its stores on multiple e-commerce platforms, including JD, Chuchujie, Mogujie, Pinduoduo, and Juanpi, and has not updated its WeChat account since early 2023 [1][2]. - Chunji's last registered product was recorded in July 2024, indicating over a year without new product launches [1]. Group 2: Historical Financial Performance - Chunji was launched in 2007 with a focus on natural skincare for young women, and at its peak, it contributed significantly to Marubi Bio's revenue, with sales rising from 144 million yuan in 2014 to 170 million yuan in 2016, accounting for 14.11% of total revenue [2]. - However, after 2016, Chunji's revenue declined to 142 million yuan by 2018, reducing its market share to 9.06% [2]. - Since Marubi Bio's IPO in 2019, Chunji's specific revenue figures have not been disclosed, but the company acknowledged a decline due to intensified market competition and limitations of traditional marketing [2]. Group 3: Strategic Shift and Market Trends - Marubi Bio's strategic shift from Chunji to its rapidly growing color cosmetics brand, Lianhuo, is evident, with Lianhuo's revenue skyrocketing from 66.17 million yuan in 2021 to an expected 1 billion yuan in 2025 [3]. - The rise of domestic color cosmetics brands, fueled by the "Guochao" trend, has contributed to Lianhuo's success, while Chunji's unclear brand positioning and fluctuating strategies led to a loss of both existing and potential customers [3]. - Industry experts suggest that Chunji's exit may be part of Marubi Bio's plan to explore a new business model, emphasizing the need for clearer brand positioning and channel strategies for future success [3].

丸美生物旗下美妆品牌春纪正在"悄然退场"。10月20日，北京商报记者发现，在淘宝天猫平台已经搜索 不到春纪旗舰店相关信息。有媒体报道，春纪天猫旗舰店发布《店铺终止经营公告》表示，"本店铺拟 于2025年10月26日自主终止经营"。而在更早的今年8月，就有多家媒体报道春纪天猫官方旗舰店下架了 所有产品链接，无法购买。 值得一提的是，北京商报记者在化妆品监管App上搜索发现，春纪产品的最后一款备案产品时间为2024 年7月30日，这意味着在过去一年多的日子里，春纪未向市场推出任何新品。从线下渠道的发展来看， 目前尚未搜索到春纪线下专柜。而这些信号似乎都在印证这一曾经颇具知名度的品牌的悄然离去。 与此同时，记者了解到，该品牌位于京东、楚楚街、蘑菇街、拼多多、卷皮等多家主流电商平台的店铺 已全部关闭。春纪微信公众号也早于2023年初停更；而春纪官方微博于2022年5月停更。 就上述相关信息，北京商报记者对丸美生物进行求证，截至目前未收到回应。 公开资料显示，丸美生物于2007年推出春纪，以"天然食材养肤"为核心理念，定位大众护肤市场，旨在 为年轻女性提供天然护肤方案。从为数不多的春纪被披露过的营收数据来看，该品牌曾是 ...

证券之星消息，10月20日化妆品板块较上一交易日下跌0.33%，丸美生物领跌。当日上证指数报收于 3863.89，上涨0.63%。深证成指报收于12813.21，上涨0.98%。化妆品板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603983 | 丸美生物 | 36.84 | -2.57% | 1.94万 | 7208.80万 | | 920123 | 芭薇股份 | 17.28 | -1.76% | 1.44万 | 2514.74万 | | 600315 | 上海家化 | 27.60 | -1.39% | C 10.84万 | 2.98亿 | | 300849 | 锦盛新材 | 13.70 | -1.30% | ¥ 4.40万 | 6072.05万 | | 603605 | 班莱雅 | 77.70 | -0.41% | 3.64万 | 2.83亿 | ...

Core Points - The cosmetics sector experienced a decline of 2.36% on October 17, with Lafang Home leading the drop [1] - The Shanghai Composite Index closed at 3839.76, down 1.95%, while the Shenzhen Component Index closed at 12688.94, down 3.04% [1] Stock Performance - Jinsheng New Material (300849) closed at 13.88, up 3.89% with a trading volume of 64,700 shares and a transaction value of 89.115 million yuan [1] - Furuida (600223) remained unchanged at 7.83, with a trading volume of 112,800 shares [1] - Marubi Biological (603983) closed at 37.81, down 0.13% with a trading volume of 11,900 shares [1] - Qingsong Co. (300132) closed at 6.14, down 1.44% with a trading volume of 145,600 shares [1] - XD+R Caiya (603605) closed at 78.02, down 1.50% with a trading volume of 48,900 shares and a transaction value of 383 million yuan [1] - Other notable declines include: - Buxiaoxing (300886) down 1.60% to 28.22 [1] - Fulejia (301371) down 1.74% to 24.30 [1] - Qingdao Kingway (002094) down 2.19% to 7.61 with a transaction value of 133 million yuan [1] - Zhiwei Co. (920123) down 2.55% to 17.59 [1] - Kesi Co. (300856) down 2.58% to 65 [1] Fund Flow - The cosmetics sector saw a net outflow of 188 million yuan from main funds, while retail investors contributed a net inflow of 215 million yuan [3] - Speculative funds experienced a net outflow of 27.0841 million yuan [3]

Group 1 - The cosmetics sector experienced a significant increase of 3.35% on October 15, with Shuiyang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] - Major stocks in the cosmetics sector showed notable price increases, with Shuiyang Co., Ltd. rising by 8.45% to a closing price of 25.03 [1] Group 2 - The net inflow of main funds in the cosmetics sector was 219 million yuan, while retail investors saw a net outflow of 222 million yuan [1] - Shanghai Jahwa's main fund net inflow was 85.02 million yuan, with a retail net outflow of 66.90 million yuan [2] - Shuiyang Co., Ltd. had a main fund net inflow of 46.76 million yuan, but a retail net outflow of 69.20 million yuan [2]

Core Insights - Marubi Biotech's stock price increased by 2.02% on October 15, reaching 38.36 CNY per share, with a total market capitalization of 15.382 billion CNY [1] - The company has seen a year-to-date stock price increase of 20.78%, but has experienced declines of 3.62% over the past five trading days, 3.91% over the past twenty days, and 5.26% over the past sixty days [1] - Marubi Biotech's main business includes the research, design, production, sales, and service of various skincare products, with revenue composition as follows: skincare 39.20%, beauty and others 29.30%, eye care 23.75%, cleansing 7.66%, and others 0.10% [1] Financial Performance - For the first half of 2025, Marubi Biotech achieved revenue of 1.769 billion CNY, representing a year-on-year growth of 30.83%, and a net profit attributable to shareholders of 186 million CNY, up 5.21% year-on-year [2] - The company has distributed a total of 983 million CNY in dividends since its A-share listing, with 610 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 36.85% to 17,400, while the average number of tradable shares per person decreased by 26.93% to 23,084 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 4.85 million shares, an increase of 1.485 million shares compared to the previous period [3]